RG
SLDB icon

Redmile Group’s Solid Biosciences SLDB Stock Holding History

Redmile Group’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.5M Buy
2,011,895
+151,353
+8% +$973K 0.96% 18
2025
Q4 		$10.5M Sell
1,860,542
-38,800
-2% -$210K 0.77% 22
2025
Q3 		$11.7M Sell
1,899,342
-16,584
-0.9% -$97K 1.14% 21
2025
Q2 		$9.33M Sell
1,915,926
-103,245
-5% -$365K 0.99% 23
2025
Q1 		$7.47M Buy
2,019,171
+1,403,925
+228% +$6.01M 0.71% 29
2024
Q4 		$2.46M Buy
+615,246
New +$3.38M 0.17% 53

Other funds holding SLDB

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return